Changeflow GovPing Healthcare & Life Sciences ASPARGO Trademark Application for Medical Instr...
Routine Notice Added Final

ASPARGO Trademark Application for Medical Instruments and Drug Delivery Devices

Favicon for changeflow.com USPTO Trademarks - Medical Devices (Class 010)
Published
Detected
Email

Summary

The USPTO has received an intent-to-use trademark application (TM90455390) for the mark ASPARGO. The application covers medical instruments, drug delivery devices, and pharmaceuticals, including sildenafil for erectile dysfunction treatment.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application, identified as TM90455390, for the mark ASPARGO. The application, filed on January 8, 2021, seeks protection for a range of goods including pump spray dispensers for medical purposes, oral spray devices for administering medicaments (specifically sildenafil for erectile dysfunction), pharmaceutical compounds, and drug delivery devices prefilled with pharmaceutical products.

This filing signifies a potential new market entry or brand expansion for products related to medical devices and pharmaceuticals. While this is a trademark application and not a regulatory rule, companies operating in the pharmaceutical and medical device sectors should be aware of new brand registrations that may impact their market or product naming strategies. No immediate compliance actions are required for other entities based on this trademark filing.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

ASPARGO

Intent to Use TM90455390 Kind: intenttouse Mar 26, 2026

Abstract

Pump spray dispensers for medical purposes; oral spray device for administering medicament; oral spay device for administering sildenafil; Pharmaceuticals compounds for the treatment of erectile dysfunction; sildenafil; oral spray formulation of sildenafil; house mark for pharmaceuticals for the treatment of erectile dysfunction; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of erectile dysfunction

Filing Date

2021-01-08

View original document →

Get daily alerts for USPTO Trademarks - Medical Devices (Class 010)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
January 8th, 2021
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM90455390

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when USPTO Trademarks - Medical Devices (Class 010) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!